Understanding Your Lung Cancer Genetics: A Path to Personalised Treatment
When you’re facing a lung cancer diagnosis, the uncertainty can feel overwhelming. You deserve answers that go beyond a simple diagnosis – you need to understand the specific genetic characteristics of your cancer to access the most effective treatments available today. Our Lung Cancer Panel 6 provides that crucial clarity, testing for three key genetic markers that determine which targeted therapies will work best for your unique situation.
What This Test Reveals About Your Cancer
This comprehensive panel examines three critical genetic markers that significantly impact treatment decisions:
- EGFR Testing: Identifies mutations that respond exceptionally well to targeted EGFR inhibitor medications
- ALK Analysis: Detects rearrangements that make your cancer highly responsive to ALK inhibitor therapies
- ROS1 Assessment: Finds fusions that open access to specific ROS1-targeted treatments
Each of these genetic variations represents a potential pathway to more effective, less toxic treatment options specifically tailored to your cancer’s unique profile.
Who Should Consider This Genetic Testing?
This test is particularly important if you:
- Have been recently diagnosed with non-small cell lung cancer (NSCLC)
- Are considering treatment options and want to explore targeted therapies
- Have tried conventional treatments with limited success
- Want to understand if you qualify for newer, more specific cancer medications
- Seek peace of mind through comprehensive genetic understanding of your cancer
Early genetic testing can significantly impact your treatment journey, potentially avoiding ineffective treatments and their associated side effects.
Why Genetic Testing Matters for Your Treatment Success
Understanding your cancer’s genetic profile transforms your treatment journey by:
- Personalising Your Treatment: Matching your specific genetic mutations with the most effective targeted therapies
- Improving Response Rates: Patients with targetable mutations often experience significantly better treatment outcomes
- Reducing Side Effects: Targeted therapies typically have fewer side effects than traditional chemotherapy
- Providing Hope and Direction: Clear genetic information empowers you and your oncologist to make confident treatment decisions
- Accessing Advanced Treatments Many newer cancer drugs require specific genetic markers for prescription
Understanding Your Results: Clear Guidance for Your Journey
Your results will clearly indicate whether your cancer contains EGFR mutations, ALK rearrangements, or ROS1 fusions. Each positive result opens specific treatment pathways:
- EGFR Positive: Eligible for EGFR inhibitor medications like gefitinib, erlotinib, or osimertinib
- ALK Positive: Can benefit from ALK inhibitors such as crizotinib, alectinib, or lorlatinib
- ROS1 Positive: May respond to ROS1-targeted therapies including crizotinib and entrectinib
Our detailed report includes clear explanations and recommendations you can discuss directly with your oncologist to develop your personalised treatment plan.
Investment in Your Health Journey
| Test Option | Regular Price | Special Price | Savings |
|---|---|---|---|
| Lung Cancer Panel 6 | ZAR 10,000 | ZAR 3,350 |
Results delivered within 5-7 days | Sample: Tumor tissue blocks
This investment in genetic understanding could save you from costly, ineffective treatments and guide you toward therapies that actually work for your specific cancer type.
Why Trust Oracle Genomics With Your Cancer Testing?
- Nationwide Coverage: Accessible testing centres in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Expert Oncology Team: Specialised geneticists and pathologists focused exclusively on cancer diagnostics
- Advanced Technology: Utilising FISH, Sanger Sequencing and IHC methods for maximum accuracy
- Rapid Turnaround: Results in 5-7 days to support timely treatment decisions
- Patient-Centred Approach: Clear, compassionate communication throughout your testing journey
Take Control of Your Cancer Journey Today
Don’t leave your treatment to chance. Understanding your cancer’s genetic profile is the first step toward more effective, personalised care. With our special pricing of ZAR 10,000, there’s never been a better time to gain the clarity you need.
Note: A doctor’s prescription is required for this test. Prescriptions are not applicable for surgery and pregnancy cases or people planning to travel abroad.
